In genomics, beyond FGFR3 mutations as important predictive and prognostic markers, other genetic alterations such as TP53, RB1, and PIK3CA also play key roles in the development and progression of bladder cancer (9, 10). Here, PIK3CA is linked to urinary bladder cancer.